SARSCoV2 convalescent plasma
/ AdventHealth
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 05, 2020
SARSCoV2 (COVID-19) Convalescent Plasma (CP) Expanded Access Protocol (EAP)
(clinicaltrials.gov)
- P; N=N/A; Available; Sponsor: AdventHealth
Clinical • New trial • Infectious Disease • Novel Coronavirus Disease
1 to 1
Of
1
Go to page
1